Marín-Fernández AB, García Medina B, Aguilar-Salvatierra A, Jiménez-Burkhardt A, Gómez-Moreno G. Jaw osteonecrosis management around a dental implant inserted 2 years before starting treatment with zoledronic acid. J Clin Exp Dent. 2015;7(3):e444-6.

 

doi:10.4317/jced.52234

http://dx.doi.org/doi:10.4317/jced.52234

 

References

1. Gómez-Moreno G, Arribas-Fernández MC, Fernández-Guerrero M, Boquete-Castro A, Aguilar-Salvatierra A, Guardia J, et al. Bisphosphonate-associated osteonecrosis of the jaw 2 years after teeth extractions: a case report solved with non-invasive treatment. Eur Rev Med Pharmacol Sci. 2014;18:1391-7.
PMid:24867519

 

2. Body JJ. Breast cancer: bisphosphonate therapy for metastasic bone disease. Clin Cancer Res. 2006;12:6258-63.
http://dx.doi.org/10.1158/1078-0432.CCR-06-0840
PMid:17062710

 

3. Bagan JV, Jimenez Y, Diaz JM, Murillo J, Sanchis JM, Poveda R, et al. Osteonecrosis of the jaws in intravenous bisphosphonate use: Proposal for a modification of the clinical classification. Oral Oncol. 2009;45:645-6.
http://dx.doi.org/10.1016/j.oraloncology.2008.05.011
PMid:18715813

 

4. Gnant M. Zoledronic acid in breast cancer: latest findings and interpretations. A review. Ther Adv Med Oncol. 2011;3:293-301.
http://dx.doi.org/10.1177/1758834011420599
PMid:22084643 PMCid:PMC3210470

 

5. Soolari N, Soolari A. Closure of an open wound associated with bisphosphonate-related osteonecrosis of the jaw in a breast cancer patient. Open Dent J. 2011;5:163-7.
http://dx.doi.org/10.2174/1874210601105010163
PMid:22135700 PMCid:PMC3227863

 

6. Bagán J, Blade J, Cozar JM, Constela M, García Sanz R, Gómez Veiga F, et al. Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonate. Med Oral Patol Oral Cir Bucal. 2007;12:336-40.

PMid:17664922

 

7. Favia G, Piattelli A, Sportelli P, Capodiferro S, Iezzi G. Osteonecrosis of the posterior mandible after implant insertion: a clinical and histological case report. Clin Impl Dent and Relat Res. 2011;13:58-63.
http://dx.doi.org/10.1111/j.1708-8208.2009.00181.x
PMid:19681933

 

8. Merigo E, Manfredi M, Meleti M, Guidotti R, Ripasarti A, Zanzucchi E, et al. Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases. Acta Biomed. 2006;77:109-17.
PMid:17172192

 

9. Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol. 2005;23:8580-7.
http://dx.doi.org/10.1200/JCO.2005.02.8670
PMid:16314620